JP2014210824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014210824A5 JP2014210824A5 JP2014168689A JP2014168689A JP2014210824A5 JP 2014210824 A5 JP2014210824 A5 JP 2014210824A5 JP 2014168689 A JP2014168689 A JP 2014168689A JP 2014168689 A JP2014168689 A JP 2014168689A JP 2014210824 A5 JP2014210824 A5 JP 2014210824A5
- Authority
- JP
- Japan
- Prior art keywords
- gastritis
- treatment
- prostaglandin
- prevention
- agonist component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000007882 Gastritis Diseases 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 150000003180 prostaglandins Chemical class 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 208000004300 Atrophic Gastritis Diseases 0.000 claims 2
- 208000036495 Gastritis atrophic Diseases 0.000 claims 2
- 241000590002 Helicobacter pylori Species 0.000 claims 2
- 208000031845 Pernicious anaemia Diseases 0.000 claims 2
- 208000016644 chronic atrophic gastritis Diseases 0.000 claims 2
- 201000001564 eosinophilic gastroenteritis Diseases 0.000 claims 2
- 229940037467 helicobacter pylori Drugs 0.000 claims 2
- 230000002980 postoperative effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000006806 disease prevention Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87044406P | 2006-12-18 | 2006-12-18 | |
| US60/870,444 | 2006-12-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Division JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014210824A JP2014210824A (ja) | 2014-11-13 |
| JP2014210824A5 true JP2014210824A5 (enExample) | 2014-12-25 |
Family
ID=39059771
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Ceased JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
| JP2014168689A Ceased JP2014210824A (ja) | 2006-12-18 | 2014-08-21 | 胃腸疾患の治療方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Ceased JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100081631A1 (enExample) |
| EP (3) | EP2548559A1 (enExample) |
| JP (2) | JP2010513551A (enExample) |
| AU (1) | AU2007334038A1 (enExample) |
| BR (1) | BRPI0721067A2 (enExample) |
| CA (1) | CA2690273A1 (enExample) |
| WO (1) | WO2008076703A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| MX2008012495A (es) | 2006-03-28 | 2009-01-07 | Javelin Pharmaceuticals Inc | Formulaciones de dosis baja de diclofenaco y beta-ciclodextrina. |
| US20090012165A1 (en) * | 2007-07-03 | 2009-01-08 | Sucampo Ag | Pharmaceutical combination of nsaid and prostaglandin compound |
| MX2013001227A (es) * | 2010-07-30 | 2013-04-24 | Allergan Inc | Compuestos y metodos para reparacion de piel. |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| RU2586040C1 (ru) * | 2014-12-25 | 2016-06-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства Здравоохранения Российской Федерации (ГБОУ ВПО НижГМА Минздрава России) | Способ диагностики идиопатической язвенной болезни желудка и двенадцатиперстной кишки |
| JP7174982B2 (ja) | 2015-06-12 | 2022-11-18 | サイモン フレイザー ユニヴァーシティー | アミド連結ｅｐ４アゴニスト－ビスホスホネート化合物およびその使用 |
| NL2018407B1 (en) * | 2017-02-22 | 2018-09-17 | Skytree B V | Improved process and apparatus for the removal of metabolic carbon dioxide from a confined space |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110298A (en) | 1993-07-13 | 1999-04-11 | Brann Mark Robert | Identification of ligands by selective amplification of cells transfected with receptors |
| EP1114816A4 (en) | 1998-09-14 | 2002-09-04 | Ono Pharmaceutical Co | SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES- $ g (V) AND MEDICINAL PRODUCTS CONTAINING THEM AS ACTIVE INGREDIENT |
| EA200300379A1 (ru) | 2000-11-27 | 2003-08-28 | Пфайзер Продактс Инк. | Селективные агонисты рецептора ep4 в лечении остеопороза |
| JP4547912B2 (ja) * | 2002-03-05 | 2010-09-22 | 小野薬品工業株式会社 | ８−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤 |
| US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| WO2006047476A2 (en) * | 2004-10-26 | 2006-05-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7893107B2 (en) * | 2005-11-30 | 2011-02-22 | Allergan, Inc. | Therapeutic methods using prostaglandin EP4 agonist components |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
-
2007
- 2007-12-11 WO PCT/US2007/087042 patent/WO2008076703A1/en not_active Ceased
- 2007-12-11 EP EP12188643A patent/EP2548559A1/en not_active Withdrawn
- 2007-12-11 JP JP2009543060A patent/JP2010513551A/ja not_active Ceased
- 2007-12-11 CA CA2690273A patent/CA2690273A1/en not_active Abandoned
- 2007-12-11 EP EP12159850A patent/EP2465506A1/en not_active Withdrawn
- 2007-12-11 BR BRPI0721067-1A patent/BRPI0721067A2/pt not_active IP Right Cessation
- 2007-12-11 US US12/519,215 patent/US20100081631A1/en not_active Abandoned
- 2007-12-11 AU AU2007334038A patent/AU2007334038A1/en not_active Abandoned
- 2007-12-11 EP EP07855057A patent/EP2120962A1/en not_active Ceased
-
2014
- 2014-08-21 JP JP2014168689A patent/JP2014210824A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014210824A5 (enExample) | ||
| NZ624922A (en) | Orally administered corticosteroid compositions | |
| EP3904502A3 (en) | Compositions and methods | |
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| JP2013014622A5 (enExample) | ||
| RU2019131148A (ru) | Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы | |
| JP2019516735A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| DOP2017000294A (es) | Unidad de dosificación orodispersable que contiene un componente estetrol | |
| JP2013032389A5 (enExample) | ||
| JP2015110588A5 (enExample) | ||
| EP3932907A3 (en) | Dextromethorphan analogs and combinations of deuterated dextromethorphan and nortriptyline for use in treating agitation and/or aggression | |
| EA201001781A1 (ru) | Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов | |
| BRPI0511327B8 (pt) | combinações de glicopirrolato e agonistas do adrenorreceptor beta2 | |
| JP2011527299A5 (enExample) | ||
| MX2018003975A (es) | Combinacion de glicosaminoglicanos y un agente antacido y sus composiciones. | |
| JP2014507477A5 (enExample) | ||
| SA517390550B1 (ar) | وحدة جرعة قابلة للتفتت في الفم تتضمن مكون أستيترول | |
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| EP2956149A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI | |
| PH12015502406A1 (en) | Orally administrable pharmaceutical composition for prevention or treatment of dry eye syndrome, comprising rebamipide or prodrug thereof | |
| JP2012528856A5 (enExample) | ||
| JP2016535794A5 (ja) | 急速崩壊性固体剤形 | |
| WO2016040814A3 (en) | Disulfide polymers and methods of use | |
| EA201270653A1 (ru) | Антагонист dpи его применение |